Expertise in
5
conditions

Dr. Richard Bergenstal

Endocrinology
3800 Park Nicollet Blvd, 
St Louis Park, MN 
Expertise in
5
conditions
3800 Park Nicollet Blvd, 
St Louis Park, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Richard Bergenstal is an Endocrinologist in St Louis Park, Minnesota. Dr. Bergenstal is highly rated in 5 conditions, according to our data. His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Gestational Diabetes.

His clinical research consists of co-authoring 273 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in MN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 5 Less Insurance Carriers -

Locations

3800 Park Nicollet Blvd, St Louis Park, MN 55416

Additional Areas of Focus

Dr. Bergenstal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
A Phase 3, Multicenter, Randomized, Parallel-Design, Open-Label Trial to Evaluate the Efficacy and Safety of LY3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (QWINT-3)
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 3
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc
Enrollment Status: Completed
Publish Date: January 15, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
An Exploratory Study Assessing Time in Target Glucose Range Using a New Titration Scheme of LY900014 and Insulin Degludec in Patients With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 03, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Degludec
Study Phase: Phase 2
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study
Enrollment Status: Completed
Publish Date: April 14, 2022
Intervention Type: Drug
Study Drugs: Glimepiride, Sitagliptin, Liraglutide, Insulin (glargine)
Study Phase: Phase 3
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
An Open-label, Multi-centre, Randomised, Single-period, Parallel Design Study to Assess the Efficacy, Safety, Utility and Psychosocial Effect of 12 Week Day and Night Automated Closed Loop Glucose Control Combined With Pump Suspend Feature Compared to Sensor Augmented Insulin Pump Therapy in Youth and Adults With Type 1 Diabetes With Sub-optimal Glucose Control Under Free Living Conditions
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

273 Total Publications

Continuous Glucose Monitoring to Guide Lifestyle Choices With a Focus on Nutrition in the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Continuous Glucose Monitoring to Guide Lifestyle Choices With a Focus on Nutrition in the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Journal: Journal of diabetes science and technology
Published: October 18, 2025
Similar Doctors
Expertise in
4
conditions
Dr. Bernhard J. Hering
Endocrinology
Expertise in
4
conditions
Dr. Bernhard J. Hering
Endocrinology
516 Delaware Street Se, Pwb First Floor, Clinic 1e, Univ. Of Minn. Physicians, 
Minneapolis, MN 
 (6.2 miles away)
612-626-6666
Languages Spoken:
English
See accepted insurances

Bernhard Hering is an Endocrinologist in Minneapolis, Minnesota. Dr. Hering is highly rated in 4 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Obesity, Islet Cell Transplantation, and Pancreatectomy.

Expertise in
3
conditions
Dr. Elizabeth R. Seaquist
Endocrinology
Expertise in
3
conditions
Dr. Elizabeth R. Seaquist
Endocrinology

University Of Minnesota Health Clinics And Surgery Center Inc

909 Fulton St Se, 
Minneapolis, MN 
 (6.4 miles away)
612-672-7422
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Elizabeth Seaquist is an Endocrinologist in Minneapolis, Minnesota. Dr. Seaquist has been practicing medicine for over 43 years is highly rated in 3 conditions, according to our data. Her top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Expertise in
14
conditions
Dr. Ann E. Kearns
Endocrinology
Expertise in
14
conditions
Dr. Ann E. Kearns
Endocrinology

Hennepin Healthcare System Inc

701 Park Ave, 
Minneapolis, MN 
 (4.9 miles away)
612-873-6963
Languages Spoken:
English
See accepted insurances

Ann Kearns is an Endocrinologist in Minneapolis, Minnesota. Dr. Kearns is highly rated in 14 conditions, according to our data. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Hyperparathyroidism, Parathyroidectomy, and Hormone Replacement Therapy (HRT).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bergenstal's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile